Souhaitez-vous accéder aux communiqués récents ?

ALPHARETTA, Ga., June 30, 2026 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a company that focuses on developing first-in-class, new non-opioid...

Exicure announced Board and committee changes, including two director appointments, one resignation, and the formation of a Compensation Committee.

VANCOUVER, British Columbia, June 30, 2026 (GLOBE NEWSWIRE) -- INDROTEK, an autonomous systems company operating across defense, critical infrastructure and commercial markets, today announced the...

ISTANBUL, June 30, 2026 (GLOBE NEWSWIRE) -- D-MARKET Electronic Services & Trading (d/b/a “Hepsiburada”) (NASDAQ: HEPS), a leading Turkish e-commerce platform, today announced the completion of...

Worldcom Public Relations Group announces its 2026–2027 Global Board and Regional Committees, strengthening leadership across its global partnership.

SOUTH SAN FRANCISCO, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease...

- Proceeds will fund advancement of ARON degrader, FX-111, to proof of concept and preclinical development of ARON RIPTAC program - Veteran biotech executive, Anna Protopapas, appointed as CEO to...

ORLANDO, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- Innventure, Inc. (NASDAQ: INV), an industrial growth conglomerate, today announced that its Board of Directors has appointed Dr. Bill Grieco as...

Consumer Brand and Digital Transformation Executive Charlie Cole Named Chief Executive Officer Andrew McLean to Transition to Advisory Role to Support Smooth Transition DODGEVILLE, Wis., June 30,...

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for...